Drugs / CBD
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03398083 Comparator | Dec 2017 → May 2018 | cannabis dependence | National Institute on Drug Abuse (NIDA) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CBD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03398083 ↗ |
| Route | Oral | “CBD (500 mg) capsule by mouth one time during the 18 day treatment period” NCT03398083 ↗ |